Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28-38.e25. https://doi.org/10.1016/j.fertnstert.2011.09.024.
Ding T, Hardiman P, Petersen I, Wang F-F, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8:96351–8. https://doi.org/10.1530/endoabs.50.p339.
Article PubMed PubMed Central Google Scholar
De Leo V, Musacchio M, Palermo V, Di Sabatino A, Morgante G, Petraglia F. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options. Drugsof Today. 2009;45:763–75. https://doi.org/10.1358/dot.2009.45.10.1429463.
Rostamtabar M, Esmaeilzadeh S, Tourani M, Rahmani A, Baee M, Shirafkan F, et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. J Cell Physiol. 2021;236:824–38. https://doi.org/10.1002/jcp.29912.
Article CAS PubMed Google Scholar
Eiras MC, Pinheiro DP, Romcy KAM, Ferriani RA, Dos RRM, Furtado CLM. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease. Reprod Sci. 2021;29:680–94. https://doi.org/10.1007/s43032-021-00516-3.
Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. https://doi.org/10.1016/j.molmet.2020.01.001.
Article CAS PubMed PubMed Central Google Scholar
Zeng X, Xie Y, Liu Y, Long S, Mo Z. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214–21. https://doi.org/10.1016/j.cca.2019.11.003.
Article ADS CAS PubMed Google Scholar
Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2021;95:531–41. https://doi.org/10.1111/cen.14421.
Zia S. Obesity: Impact and Outcome on Infertility—A Literature Review. Open J Obstet Gynecol. 2023;13:214–40. https://doi.org/10.4236/ojog.2023.132023.
Demissie S, Levy D, Benjamin EJ, Cupples LA, Gardner JP, Herbert A, et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell. 2006;5:325–30. https://doi.org/10.1111/j.1474-9726.2006.00224.x.
Article CAS PubMed Google Scholar
Barber TM, McCarthy MI, Wass JAH, Franks S. Obesity and Polycystic Ovary Syndrome. Clin Endocrinol (Oxf). 2006;65:137–45. https://doi.org/10.1111/j.1365-2265.2006.02587.x.
Article CAS PubMed Google Scholar
Barber TM, Hanson P, Weickert MO, Franks S. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clin Med Insights Reprod Heal. 2019;13:117955811987404. https://doi.org/10.1177/1179558119874042.
Gielen M, Hageman GJ, Antoniou EE, Nordfjall K, Mangino M, Balasubramanyam M, et al. Body mass index is negatively associated with telomere length: A collaborative cross-sectional meta-analysis of 87 observational studies. Am J Clin Nutr. 2018;108:453–75. https://doi.org/10.1093/ajcn/nqy107.
Article PubMed PubMed Central Google Scholar
Blackburn EH. Telomere states and cell fates. Nature. 2000;408:53–6. https://doi.org/10.1038/35040500.
Article ADS CAS PubMed Google Scholar
Satoh H, Hiyama K, Takeda M, Awaya Y, Watanabe K, Ihara Y, et al. Telomere shortening in peripheral blood cells was related with aging but no with white blood cell count. J Hum Genet. 1996;41:413–7.
Calado R, Chen J. Telomerase: not just for the elongation of telomeres. BioEssays. 2006;28:109–12. https://doi.org/10.1002/bies.20365.
Article CAS PubMed Google Scholar
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266(5193):2011-5. https://doi.org/10.1126/science.7605428.
Kazemi M, Jarrett BY, Brink HV, Lin AW, Hoeger KM, Spandorfer SD, et al. Obesity, insulin resistance, and hyperandrogenism mediate the link between poor diet quality and ovarian dysmorphology in reproductive-aged women. Nutrients. 2020;12:1–24. https://doi.org/10.3390/nu12071953.
Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood. 2009;114:2236–43. https://doi.org/10.1182/blood-2008-09-178871.
Article CAS PubMed PubMed Central Google Scholar
Guo C, Armbruster BN, Price DT, Counter CM. In vivo regulation of hTERT expression and telomerase activity by androgen. J Urol. 2003;170:615–8. https://doi.org/10.1097/01.ju.0000074653.22766.c8.
Pedroso DCC, Miranda-Furtado CL, Kogure GS, Meola J, Okuka M, Silva C, et al. Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome. Fertil Steril. 2015;103:542-547.e2. https://doi.org/10.1016/j.fertnstert.2014.10.035.
Article CAS PubMed Google Scholar
Li Q, Du J, Feng R, Xu Y, Wang H, Sang Q, et al. A possible new mechanism in the pathophysiology of polycystic ovary syndrome (PCOS): The discovery that leukocyte telomere length is strongly associated with PCOS. J Clin Endocrinol Metab. 2014;99:234–40. https://doi.org/10.1210/jc.2013-3685.
Vasilopoulos E, Fragkiadaki P, Kalliora C, Fragou D, Docea AO, Vakonaki E, et al. The association of female and male infertility with telomere length. Int J Mol Med. 2019;44:375–89. https://doi.org/10.3892/ijmm.2019.4225.
Article CAS PubMed PubMed Central Google Scholar
Mundstock E, Sarria EE, Zatti H, Mattos Louzada F, Kich Grun L, Herbert Jones M, et al. Effect of obesity on telomere length: Systematic review and meta-analysis. Obesity. 2015;23:2165–74. https://doi.org/10.1002/oby.21183.
The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7. https://doi.org/10.1093/humrep/deh098
Malachias M, Souza W, Plavnik F, et al. VII Diretriz Brasileira de Hipertão Arterial. Arq Bras Cardiol. 2010;95:1–4. https://doi.org/10.5935/abc.20160151.
Cascella T, Palomba S, Tauchmanovà L, Manguso F, Di Biase S, Labella D, et al. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2006;91:4395–400. https://doi.org/10.1210/jc.2006-0399.
Article CAS PubMed Google Scholar
Friedewald W, Levy R, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
Article CAS PubMed Google Scholar
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. https://doi.org/10.1007/BF00280883.
Article CAS PubMed Google Scholar
Lai TP, Wright WE, Shay JW. Comparison of telomere length measurement methods. Philos Trans R Soc B Biol Sci. 2018;373. https://doi.org/10.1098/rstb.2016.0451.
Gruber HJ, Semeraro MD, Renner W, Herrmann M. Telomeres and age-related diseases. Biomedicines. 2021;9:1335. https://doi.org/10.3390/biomedicines9101335.
Tajada M, Dieste-Pérez P, Sanz-Arenal A, Pérez-Roncero G, López-Baena MT, Pérez-López FR. Leukocyte telomere length in women with and without polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2022;38:391–7. https://doi.org/10.1080/09513590.2022.2047922.
Article CAS PubMed Google Scholar
Pölönen J, Pinola P, Ronkainen J, Blakemore AI, Buxton JL, Tapanainen JS, et al. Polycystic ovary syndrome and leukocyte telomere length: cross-sectional and longitudinal changes. Eur J Endocrinol. 2022;187:651–61. https://doi.org/10.1530/EJE-22-0462.
Article PubMed PubMed Central Google Scholar
Miranda-Furtado CL, Ramos FKP, Kogure GS, Santana-Lemos BA, Ferriani RA, Calado RT, et al. A Nonrandomized Trial of Progressive Resistance Training Intervention in Women with Polycystic Ovary Syndrome and Its Implications in Telomere Content. Reprod Sci. 2016;23:644–54. https://doi.org/10.1177/1933719115611753.
Article CAS PubMed Google Scholar
Kogure GS, Miranda-Furtado CL, Pedroso DCC, Ribeiro VB, Eiras MC, Silva RC, et al. Effects of progressive resistance training on obesity indices in polycystic ovary syndrome and the relationship with telomere length. J Phys Act Heal. 2019;16:601–7. https://doi.org/10.1123/jpah.2018-0256.
Nourbakhsh M, Golestani A, Zahrai M, Modarressi MH, Malekpour Z, Karami-Tehrani F. Androgens stimulate telomerase expression, activity and phosphorylation in ovarian adenocarcinoma cells. Mol Cell Endocrinol. 2010;330:10–6. https://doi.org/10.1016/j.mce.2010.07.021.
Article CAS PubMed Google Scholar
Pedroso DCC, Santana VP, Donaires FS, Picinato MC, Giorgenon RC, Santana BA, et al. Telomere Length and Telomerase Activity in Immature Oocytes and Cumulus Cells of Women with Polycystic Ovary Syndrome. Reprod Sci. 2020;27:1293–303. https://doi.org/10.1007/s43032-019-00120-6.
Article CAS PubMed Google Scholar
Wang C, Shen F, Zhu Y, Fang Y, Lu S. Telomeric repeat-containing RNA (TERRA) related to polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2017;86:552–9. https://doi.org/10.1111/cen.13283.
留言 (0)